Top Markets
Coin of the day
Imagion Biosystems Limited Imagion Biosystems Limited

Imagion Biosystems Limited

IBX
Classifica tra le azioni #35262
Imagion Biosystems Limited operates as a medical imaging company that uses... Imagion Biosystems Limited operates as a medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases in Australia. The company is involved in nanotechnology; biotechnology; medical imaging using magnetic resonance; and cancer diagnostics businesses. It develops MagSense, which is in Phase 2 for the treatment of HER2 breast cancers, as well as advancing the research and development programs for prostate and ovarian cancer. It also develops PrecisionMRX, an iron oxide nanoparticle to magnetic relaxometry. The company has collaboration agreement with Wayne State University to develop optimised MRI sequences which is in Phase 2 study of for the MagSense imaging agent. Imagion Biosystems Limited was incorporated in 2016 and is based in Melbourne, Australia.
Prezzo delle azioni
$0.00775813
Ultima sincronizzazione: 2026-08-14
Capitalizzazione di mercato
$4.19M
Variazione (1 giorno)
-15.38%
Variazione (1 anno)
-20.49%
Paese
AU
Scambia Imagion Biosystems Limited (IBX)

Categoria

Rapporto P/B per Imagion Biosystems Limited (IBX)
Rapporto P/B al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Imagion Biosystems Limited, il rapporto P/B attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/B per Imagion Biosystems Limited da 2026 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
Non abbastanza dati per le date fornite.
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
4.1431 -
US
2.7156 -
US
- -
CN
24.3791 -
US
27.366 -
US